Compare MACOM Technology (MTSI) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MACOM Technology vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? MACOM Technology trades at $324.26 (market cap $24.61B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.51 (market cap $2.27B). The key difference: MACOM Technology is far larger — about 10.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is more actively traded (4,179,659 versus 1,594,575). Which is the better fit depends on your goals.
| MTSI | SLS | |
|---|---|---|
Market Cap | $24.61B | $2.27B |
Volume | 1,594,575 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $409.68 | $15.46 |
52-Week Low | $122.18 | $1.39 |
Typical Hold Time | 6 Days | — |
Enterprise Value | $24.32B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About MACOM Technology
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
